Insomnia Clinical Trial
Official title:
Music Interventions for the Facilitation of Sleep in the Acute Geriatric Setting
NCT number | NCT05398419 |
Other study ID # | SMHC-21-21 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | April 19, 2022 |
Est. completion date | October 2022 |
Sleep disturbance is a common problem experienced by older patients, especially in the acute care setting, and has detrimental effects on patients' health and recovery. There is a keen focus on non-pharmacological interventions because of the high risk of side effects related to pharmacotherapy. Music is safe and cost-effective, and there is a growing body of evidence for its potential health benefits. The purpose of our study is to examine the impact of music listening interventions on the facilitation of sleep for patients admitted to the geriatric assessment unit (GAU). The investigators predict that a musical listening exercise will more effectively contribute to the facilitation of sleep compared to non-musical sounds and compared to standard of care on the GAU. The investigators plan to conduct this study as a feasibility study. It will be a 3-arm randomized controlled trial where participants will be randomized to either: (1) music listening intervention, (2) non-musical sounds involving nature sounds, or (3) standard of care on the GAU. The intervention will take place over 7 consecutive nights. The primary outcome will be sleep quality, which will be measured objectively using sleep logs and subjectively through patients' own perspectives of their sleep through the Insomnia Severity Index. Secondary outcomes will include patients' sleep quality assessed by smart watches, which the investigators will evaluate to see if the data correlates to the sleep logs and patients' subjective view of their sleep. Other secondary outcomes will include patients' mood, level of pain, number medications used for sleep, duration of stay in hospital, patients' level of enjoyment of the music or non-musical sounds, and feasibility measures. As this is a feasibility study, the goal is to show that it is possible to conduct a larger study with the same objectives and methodology. The ultimate goal is to create high-quality evidence to support (or refute) our hypothesis that music listening interventions are effective at facilitating sleep for patients admitted to the GAU. This would be a safe and cost-effective intervention to improve the health outcomes of this vulnerable population.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | October 2022 |
Est. primary completion date | October 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 65 Years and older |
Eligibility | Inclusion Criteria: - This study will include patients admitted to the GAU at St. Mary's hospital in Montréal over the six-month study period (March to August 2022). As many of the patients admitted to the GAU have major neurocognitive disorder (MNCD), the investigators will include them in our study (MNCD of any stage, including Alzheimer's disease). Furthermore, the investigators will include patients who take medications for sleep in our study, and they will be randomized into the 3 groups like all the other participants. - The patients' baseline characteristics will be noted upon entry into the study: admitting diagnosis, demographics (age, sex), whether they have MNCD, and their music sophistication. Patients' music sophistication will be evaluated using the General Musical Sophistication Subscale (GMSS) which is embedded within the Goldsmiths Musical Sophistication Index (Gold-MSI). Furthermore, as the investigators will be including patients who use medications for sleep in our study, the investigators will note what type of medication(s) the participants are taking. Specifically, the investigators will categorize the medications in the following categories: benzodiazepines, antidepressants, antipsychotics, melatonin or other; and the investigators will note if the indication is specifically for sleep or not. Exclusion Criteria: - Patients who already listen to music or non-musical sounds as part of their sleep routine. - Patients with medical instability which limits their ability to participate in the study (determined by the patient's treating physician). - Patients who have a diagnosis of a sleep disorder including obstructive sleep apnea and REM sleep behaviour disorder. - Patients who are unable to communicate in English or French. - Patients with behavioural issues that limit their participation in the study; specifically, those that have agitation or hyperactivity that limits their compliance with the intervention as can be seen in cases of severe BPSD (Behavioural and Psychological Symptoms of Dementia) or hyperactive delirium. - Patients with severe hearing impairment, specifically those for whom their hearing impairment affects their ability to communicate their consent for this study and to listen to music. |
Country | Name | City | State |
---|---|---|---|
Canada | St. Mary's Hospital Center | Montréal | Quebec |
Lead Sponsor | Collaborator |
---|---|
McGill University | St. Mary's Hospital Foundation |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sleep quality measured subjectively via the Insomnia Severity Index (ISI) questionnaire | Sleep quality will also be measured subjectively through patients' own perspectives of their sleep with the Insomnia Severity Index (ISI) questionnaire which will be administered to the patients daily. The ISI is a questionnaire which has seven questions that pertain to participants' severity of insomnia symptoms. Participants are asked to answer each question on a scale of 0 to 4 (0 being asymptomatic and 4 being very symptomatic). The seven answers are added up to get a total score which ranges between 0 and 28. The higher the score, the more severe the insomnia is. The ISI questions will be slightly modified so that the questions focus on patients' latest night of sleep, not on their sleep over the past 2 weeks, as this questionnaire will be administered daily. The ISI has been shown to be a reliable and valid tool as an outcome measure in insomnia treatment and research in older patients. | 7 days | |
Primary | Total sleep time measured objectively via sleep logs | Total sleep time will be measured objectively by sleep logs. This will be done by the overnight nurses who will complete a form in the morning where they will write down the following for each participant:
the time of sleep onset the wake time in the morning the number and duration of awakenings during the night (if there are any). The research assistants will pick up the form the next day to collect that data. With this information, the investigators will be able to calculate the total sleep time of each participant for each night in the study. |
7 days | |
Primary | Number of awakenings during the night measured objectively via sleep logs | The number of awakenings will be measured objectively by sleep logs. This will be done by the overnight nurses who will complete a form in the morning where they will write down the number and duration of awakenings during the night (if there are any) for each participant as noted above. The research assistants will pick up the form the next day to collect that data. | 7 days | |
Secondary | Total sleep time assessed via smart watches | The patients will wear smart watches (Samsung Galaxy Fit2) at all times throughout the study period. The smart watches assess sleep quality by tracking a set of non-staging sleep parameters including total sleep time. The data collected from the smart watches will be time stamped and extracted by the study investigator without any identifying information. The investigators will assess if the data from the smart watches correlates to patients' sleep logs and their subjective view of their sleep quality. | 7 days | |
Secondary | Sleep onset latency assessed via smart watches | The patients will wear smart watches (Samsung Galaxy Fit2) at all times throughout the study period. The smart watches assess sleep quality by tracking a set of non-staging sleep parameters including sleep onset latency which is defined at the time that it takes to accomplish the transition from full wakefulness to sleep. | 7 days | |
Secondary | Wake after sleep onset assessed via smart watches | The patients will wear smart watches (Samsung Galaxy Fit2) at all times throughout the study period. The smart watches assess sleep quality by tracking a set of non-staging sleep parameters including wake after sleep onset which refers to periods of wakefulness occurring after defined sleep onset. | 7 days | |
Secondary | Sleep efficiency assessed via smart watches | The patients will wear smart watches (Samsung Galaxy Fit2) at all times throughout the study period. The smart watches assess sleep quality by tracking a set of non-staging sleep parameters including sleep efficiency which is defined as the amount of time actually asleep divided by the time spent in bed. | 7 days | |
Secondary | Mood assessed via visual analog mood scale | The data on patients' mood will be assessed via visual analog mood scale of specifically 8 emotions: afraid, confused, sad, angry, energetic, tired, happy, and tense. The visual analog mood scale includes 8 sets of a drawing of two faces connected by a long line. A "neutral" face will appear at the top of the line and a face showing an emotion will appear at the bottom of the line. The name of the emotion the face represents will be printed beneath the face. For each emotion, the participants are asked to place a mark across the line at the point which best describes how they are feeling at that moment. The distance between the "neutral" face and the mark placed by the participant will be measured in millimeters (mm) ranging between 0 and 80 mm. The higher the distance, the more intensely the participant is feeling the associated emotion. The visual analog mood scale will be administered to the participants daily throughout the study period. | 7 days | |
Secondary | Pain level assessed via a visual analog pain scale | Pain level be assessed via a visual analog scale that the patients will be asked to answer daily. The visual analog pain scale is a pain scale from 0 to 10 with faces along a line, with 0 representing "no pain" and 10 representing "worst pain." Participants are asked to choose a number from 0 to 10 which best describes how they are feeling. The higher the number, the higher the level of pain. | 7 days | |
Secondary | Medications used for sleep | The data on the number of medications used for sleep (PRNs and regular medications) will be gathered at the nursing report in the morning after the night shift, as well as via chart review. The name of the medication, the dose, and the time of administration will be recorded. | 7 days | |
Secondary | Enjoyment of intervention | The investigators will assess how much the patients enjoy the selected music and non-musical sounds in our study by asking them to rate their music enjoyment on a scale of 0 to 10 and by noting their qualitative comments on the music or non-musical sounds. These questions will be asked to the patients daily. | 7 days | |
Secondary | Protocol adherence | Data on protocol adherence, specifically whether the patients kept their headphones on throughout the night, or whether they turned the music off (by checking the mp3 player), will be gathered at the nursing report in the morning after the night shift. | 7 days | |
Secondary | Noise level | The investigators plan to measure the noise level present around the participants at night by placing a sound recorder at their bedside each night. | 7 days | |
Secondary | Duration of stay in hospital | The data on duration of stay in hospital will be gathered via chart review. | 7 days | |
Secondary | Number of participations as a feasibility measure | As this is a feasibility study, the investigators will record the total number of participations in the study. | 6 months | |
Secondary | Number of refusals as a feasibility measure | As this is a feasibility study, the investigators will record the total number of refusals throughout the study. | 6 months | |
Secondary | Number of eligible participants as a feasibility measure | As this is a feasibility study, the investigators will record the total number of eligible participants throughout the study. | 6 months | |
Secondary | Number of exclusions as a feasibility measure | As this is a feasibility study, the investigators will record the total number of exclusions throughout the study. | 6 months | |
Secondary | Availability of the data as a feasibility measure | As this is a feasibility study, the investigators will record the availability of the data; more specifically, they will record how often each of the above outcome measures were not available/ not completed throughout the study. | 6 months | |
Secondary | Time needed to collect the data as a feasibility measure | As this is a feasibility study, the investigators will record the time needed to collect the data; more specifically, they will record the total number of 4-hour shifts that were worked by the research assistants throughout the study. | 6 months | |
Secondary | Cost of the study as a feasibility measure | As this is a feasibility study, the investigators will record the total cost of the study including the cost of the equipment (smart watches, headphones, MP3 players, sound recorders) and the salary of the research assistants. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT05963542 -
Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia
|
N/A | |
Completed |
NCT06339853 -
Study of Efficacy of Digital Cognitive Behavioral Therapy With Wearable Device for Insomnia
|
N/A | |
Recruiting |
NCT04069247 -
Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia
|
N/A | |
Completed |
NCT04493593 -
Internet-delivered CBT-I (Space for Sleep): Pilot and Feasibility
|
N/A | |
Recruiting |
NCT06278077 -
Neurexan - a Clinical Trial in Short-Term Insomnia Patients
|
Phase 2 | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Completed |
NCT04661306 -
The Better Sleep for Supporters With Insomnia Study
|
N/A | |
Recruiting |
NCT06207279 -
Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
|
||
Recruiting |
NCT06006299 -
Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC)
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Completed |
NCT04564807 -
Testing an Online Insomnia Intervention
|
N/A | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Completed |
NCT04035200 -
Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation
|
Phase 2 | |
Active, not recruiting |
NCT05027438 -
Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention
|
N/A | |
Recruiting |
NCT06053840 -
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia
|
Phase 4 | |
Not yet recruiting |
NCT06348082 -
Project Women's Insomnia Sleep Health Equity Study (WISHES)
|
N/A | |
Not yet recruiting |
NCT06363799 -
Osteopathic Protocol for Insomnia in College Students
|
N/A | |
Not yet recruiting |
NCT06025968 -
Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis
|
N/A | |
Not yet recruiting |
NCT05991492 -
Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application
|
N/A |